{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:10:04Z","timestamp":1795201804397,"version":"4.10.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Cutaneous polyarteritis nodosa (CPAN) is a necrotizing vasculitis of the middle-size vessels, confined to the skin. We conducted a systematic review in order to identify studies evaluating the different treatment modalities used in CPAN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This systematic review was conducted according to PRISMA guidelines, registered in PROSPERO: CRD42020222195. PubMed\/Medline databases were searched from inception to December of 2020 using the terms: (Polyarteritis nodosa[Title\/Abstract]) AND ((therapy[Title\/Abstract]) OR (management[Title\/Abstract]) OR (treatment[Title\/Abstract]))\u2019 and \u2018Cutaneous arteritis [Title\/Abstract]\u2019. Articles evaluating pertaining to the management of CPAN in adults were eligible for inclusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of seven eligible case series with 325 unique patients were included. No study included a control population. In general, systemic corticosteroids were widely used as induction treatment. Immunosuppressive agents combined with corticosteroids were AZA, hydroxychloroquine, sulfasalazine, sulphapyridine, CYC, MTX, mycophenolate, tacrolimus, rituxima and thalidomide. Other agents utilized in the studies were dapsone, colchicine, non-steroid anti-inflammatory drugs, salicylates, warfarin and clopidogrel. In some studies, the presence of ulcerations was associated with an increased risk of relapse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The evidence available regarding the management of patients with CPAN is limited at best. Further studies are needed in order to evaluate the effect of treatment on disease remission, relapses and mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab402","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T19:14:24Z","timestamp":1619723664000},"page":"4039-4047","source":"Crossref","is-referenced-by-count":25,"title":["Therapeutic options for cutaneous polyarteritis nodosa: a systematic review"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9726-7144","authenticated-orcid":false,"given":"Eleni","family":"Papachristodoulou","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Cyprus Medical School, Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-1569","authenticated-orcid":false,"given":"Loukas","family":"Kakoullis","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cyprus Medical School, Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tiniakou","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Parperis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus"},{"name":"Department of Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"2021090119444313700_keab402-B1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2014.01.029","article-title":"Diagnosis and classification of polyarteritis nodosa","volume":"48\u201349","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2014","journal-title":"J Autoimmun"},{"key":"2021090119444313700_keab402-B2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/rheumatology\/kel091","article-title":"Polyarteritis nodosa when applying the Chapel Hill nomenclature\u2013a descriptive study on ten patients","volume":"45","author":"Selga","year":"2006","journal-title":"Rheumatology"},{"key":"2021090119444313700_keab402-B3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2230.1983.tb01744.x","article-title":"The wide clinical spectrum of polyarteritis nodosa with cutaneous involvement","volume":"8","author":"Thomas","year":"1983","journal-title":"Clin Exp Dermatol"},{"key":"2021090119444313700_keab402-B4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.amjmed.2017.02.006","article-title":"Inner Peace: cutaneous polyarteritis nodosa","volume":"130","author":"Parperis","year":"2017","journal-title":"Am J Med"},{"key":"2021090119444313700_keab402-B5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3400\/avd.ra.12.00061","article-title":"Cutaneous polyarteritis nodosa: an update","volume":"5","author":"Furukawa","year":"2012","journal-title":"Ann Vasc Dis"},{"key":"2021090119444313700_keab402-B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00403-008-0898-2","article-title":"Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria","volume":"301","author":"Nakamura","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"2021090119444313700_keab402-B7"},{"key":"2021090119444313700_keab402-B8","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2021090119444313700_keab402-B9","first-page":"1","article-title":"2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides","volume-title":"Arthritis Rheum","author":"Jennette","year":"2013"},{"key":"2021090119444313700_keab402-B10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaad.2009.10.033","article-title":"Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa","volume":"63","author":"Kawakami","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2021090119444313700_keab402-B11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2021090119444313700_keab402-B12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Evid Based Med"},{"key":"2021090119444313700_keab402-B13","first-page":"123","article-title":"Primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoproliferative disorder: where do we stand? A systematic review","volume":"17","author":"Salah","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"2021090119444313700_keab402-B14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MD.0b013e3182115508","article-title":"Correlation of livedo racemosa, cutaneous inflammatory plaques, and antiphospholipid antibodies in patients with cutaneous polyarteritis nodosa","volume":"90","author":"Kawakami","year":"2011","journal-title":"Medicine"},{"key":"2021090119444313700_keab402-B15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1346-8138.12303","article-title":"Treatment for cutaneous arteritis patients with mononeuritis multiplex and elevated C-reactive protein","volume":"40","author":"Kawakami","year":"2013","journal-title":"J Dermatol"},{"key":"2021090119444313700_keab402-B16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2133.1997.6601645.x","article-title":"Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases","volume":"136","author":"Daoud","year":"1997","journal-title":"Br J Dermatol"},{"key":"2021090119444313700_keab402-B17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1346-8138.2009.00752.x","article-title":"Cutaneous polyarteritis nodosa: a report of 16 cases with clinical and histopathological analysis and a review of the published work","volume":"37","author":"Ishiguro","year":"2010","journal-title":"J Dermatol"},{"key":"2021090119444313700_keab402-B18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/acr.23007","article-title":"Clinical spectrum of medium-sized vessel vasculitis","volume":"69","author":"Alibaz-Oner","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2021090119444313700_keab402-B19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/03009742.2018.1551965","article-title":"Four distinct clinical phenotypes of vasculitis affecting medium-sized arteries","volume":"48","author":"Shirai","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2021090119444313700_keab402-B20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamadermatol.2018.1601","article-title":"Clinical and laboratory markers associated with relapse in cutaneous polyarteritis nodosa","volume":"154","author":"Kato","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2021090119444313700_keab402-B21","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/ddg.14271","article-title":"Manifestations, clinical course and prognostic markers in cutaneous polyarteritis nodosa","volume":"18","author":"Munera-Campos","year":"2020","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab402\/38831151\/keab402.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4039\/40215200\/keab402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4039\/40215200\/keab402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:46:14Z","timestamp":1630525574000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/9\/4039\/6263845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5,4]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab402","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,5,4]]}}}